Skip to main content
EGFR blockade prevents glioma escape from BRAFV600E targeted therapy
Published Web Location
http://europepmc.org/articles/PMC4673141?pdf=renderNo data is associated with this publication.
Abstract
Mutational activation of BRAF (BRAFV600E) occurs in pediatric glioma and drives aberrant MAPK signaling independently of upstream cues. Targeted monotherapy against BRAFV600E displays efficacy in pre-clinical models of glioma, however
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.